Mercer Global Advisors’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,979
Closed -$436K 2117
2024
Q3
$436K Sell
6,979
-118
-2% -$8.52K ﹤0.01% 1405
2024
Q2
$479K Buy
7,097
+3,862
+119% +$270K ﹤0.01% 1322
2024
Q1
$256K Sell
3,235
-461
-12% -$37.7K ﹤0.01% 1654
2023
Q4
$287K Buy
3,696
+423
+13% +$31.3K ﹤0.01% 1629
2023
Q3
$230K Buy
3,273
+513
+19% +$38.3K ﹤0.01% 1695
2023
Q2
$220K Sell
2,760
-5,659
-67% -$409K ﹤0.01% 1691
2023
Q1
$608K Sell
8,419
-5,212
-38% -$406K ﹤0.01% 1107
2022
Q4
$1.12M Buy
13,631
+741
+6% +$61.1K 0.01% 870
2022
Q3
$1.01M Buy
12,890
+5,408
+72% +$432K 0.01% 839
2022
Q2
$506K Buy
7,482
+1,041
+16% +$72.6K ﹤0.01% 1137
2022
Q1
$422K Buy
6,441
+2,866
+80% +$166K ﹤0.01% 1316
2021
Q4
$217K Sell
3,575
-8,913
-71% -$531K ﹤0.01% 1618
2021
Q3
$796K Buy
12,488
+1,140
+10% +$72K 0.01% 968
2021
Q2
$712K Buy
+11,348
New +$712K 0.01% 979

Other funds holding ACHC

Mercer Global Advisors's ACHC Position: Q4 2024 in Review

Mercer Global Advisors sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 6,979 shares — an estimated $436K sold.

Mercer Global Advisors first reported a position in ACHC in Q2 2021 and held it in 14 quarters. The position peaked at $1.12M in Q4 2022. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.

  • Mercer Global Advisors reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
  • Mercer Global Advisors sold 6,979 Acadia Healthcare shares in Q4 2024, an estimated $436K.
  • Mercer Global Advisors first reported a position in Acadia Healthcare in Q2 2021 and held it in 14 quarters.
  • Mercer Global Advisors's Acadia Healthcare position peaked at $1.12M in Q4 2022.
  • 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.

Based on Mercer Global Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.